Inozyme Pharma, Inc. - Common stock, par value $0.0001 per share (INZY)

102 filings reported holding INZY - Inozyme Pharma, Inc. - Common stock, par value $0.0001 per share as of Q3 2024.
Inozyme Pharma, Inc. - Common stock, par value $0.0001 per share (INZY) has 88 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 54.6M shares of 64.5M outstanding shares and own 84.61% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (5.67M shares), Pivotal bioVenture Partners Investment Advisor LLC (4.49M shares), Sofinnova Investments, Inc. (4.28M shares), EVENTIDE ASSET MANAGEMENT, LLC (4.13M shares), Rock Springs Capital Management LP (3.8M shares), BlackRock, Inc. (3.49M shares), SAMLYN CAPITAL, LLC (3.26M shares), Affinity Asset Advisors, LLC (2.82M shares), VANGUARD GROUP INC (2.62M shares), and FMR LLC (2.48M shares).
This table shows the top 88 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.